Phase III study of 18F-PSMA-1007 versus 18F-fluorocholine PET/CT for localization of prostate cancer biochemical recurrence: a prospective, randomized, crossover …
P Olivier, AL Giraudet, A Skanjeti, C Merlin… - Journal of Nuclear …, 2023 - Soc Nuclear Med
The objective of this study was to compare 18F-PSMA-1007 PET/CT and 18F-fluorocholine
PET/CT for the localization of prostate cancer (PCa) biochemical recurrence. Methods: This …
PET/CT for the localization of prostate cancer (PCa) biochemical recurrence. Methods: This …
[HTML][HTML] PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic …
CL Deijen, GL Vrijenhoek, EE Schaake… - Clinical and translational …, 2021 - Elsevier
Background In patients with oligometastatic recurrent prostate cancer, standard treatment is
androgen deprivation therapy (ADT). However, ADT has many potential side effects that may …
androgen deprivation therapy (ADT). However, ADT has many potential side effects that may …
Kinetic modeling and parametric imaging of 18F‐PSMA‐11: An evaluation based on total‐body dynamic positron emission tomography scans
H Yuan, G Zhang, T Sun, J Ren, Q Zhang… - Medical …, 2024 - Wiley Online Library
Background The prostate‐specific membrane antigen (PSMA) targeted positron‐emitting
tomography (PET) tracers are increasingly used in clinical practice, with novel tracers …
tomography (PET) tracers are increasingly used in clinical practice, with novel tracers …
Early injection of furosemide increases detection rate of local recurrence in prostate cancer patients with biochemical recurrence referred for 68Ga-PSMA-11 PET/CT
C Uprimny, S Bayerschmidt, AS Kroiss… - Journal of Nuclear …, 2021 - Soc Nuclear Med
The aim of this study was twofold. First, we aimed to assess the impact of forced diuresis with
early furosemide injection on the detection rate of local recurrence in prostate cancer …
early furosemide injection on the detection rate of local recurrence in prostate cancer …
The performance of FDA-approved PET imaging agents in the detection of prostate cancer
M Li, R Zelchan, A Orlova - Biomedicines, 2022 - mdpi.com
Positron emission tomography (PET) incorporated with X-ray computed tomography
(PET/CT) or magnetic resonance imaging (PET/MRI) is increasingly being used as a …
(PET/CT) or magnetic resonance imaging (PET/MRI) is increasingly being used as a …
Pattern of Prostate Cancer Recurrence Assessed by 68Ga-PSMA-11 PET/CT in Men Treated with Primary Local Therapy
IO Lawal, T Lengana, GO Popoola… - Journal of Clinical …, 2021 - mdpi.com
Imaging plays a vital role in detecting the recurrence of prostate cancer (PCa) to guide the
choice of salvage therapy. Gallium-68 prostate-specific membrane antigen positron …
choice of salvage therapy. Gallium-68 prostate-specific membrane antigen positron …
Comments to “Survey by the ANSM of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT”
F Giammarile, S Fanti - European Journal of Nuclear Medicine and …, 2021 - Springer
However, there are other points that should be carefully considered, especially in view of the
fact that the survey reported in the paper was promoted by a National Agency, namely the …
fact that the survey reported in the paper was promoted by a National Agency, namely the …
Comparison of early imaging and imaging 60 min post-injection after forced diuresis with furosemide in the assessment of local recurrence in prostate cancer patients …
S Bayerschmidt, C Uprimny, AS Kroiss, J Fritz, B Nilica… - Diagnostics, 2021 - mdpi.com
Background: 68Ga-PSMA-11 PET/CT is a promising method for the assessment of local
recurrence (LR) in prostate cancer (PCa) patients. The aim of this study was to evaluate the …
recurrence (LR) in prostate cancer (PCa) patients. The aim of this study was to evaluate the …
Imaging quality of an artificial intelligence denoising algorithm: validation in 68Ga PSMA-11 PET for patients with biochemical recurrence of prostate cancer
C Margail, C Merlin, T Billoux, M Wallaert, H Otman… - EJNMMI research, 2023 - Springer
Abstract Background 68 Ga-PSMA PET is the leading prostate cancer imaging technique,
but the image quality remains noisy and could be further improved using an artificial …
but the image quality remains noisy and could be further improved using an artificial …
PSMA-11 PET/CT for detection of recurrent prostate cancer in patients with negative choline PET/CT
F Pinot, R Le Pennec, R Abgral, F Blanc-Béguin… - Clinical Genitourinary …, 2023 - Elsevier
Abstract Introduction Prostate adenocarcinoma (CaP) is the leading cancer in men. After
curative treatment, from 27% to 53% of patients will experience biochemical recurrence …
curative treatment, from 27% to 53% of patients will experience biochemical recurrence …